Literature DB >> 16840901

[Middle ear cholesteatoma].

D Ayache1, S Schmerber, J P Lavieille, G Roger, B Gratacap.   

Abstract

Cholesteatoma is a serious form of chronic otitis media. The aim of this paper is to present the state of the art of disease management, including recent data from the literature and the authors' derived from their Mentors' teaching, Professor Pierre Roulleau (Paris, France) and Professor Robert Charachon (Grenoble, France). The main recent advances concern the use of cartilage grafts to reconstruct the canal wall and/or tympanic membrane (allowing a significant reduction in residual cholesteatoma) and progress in medical imaging allowing more acute preoperative determination of extension of the cholesteatoma (in order to propose an optimally designed surgical technique) and a less invasive postoperative follow-up.

Entities:  

Mesh:

Year:  2006        PMID: 16840901     DOI: 10.1016/s0003-438x(06)76653-1

Source DB:  PubMed          Journal:  Ann Otolaryngol Chir Cervicofac        ISSN: 0003-438X


  4 in total

1.  Role of High Resolution Computed Tomography of Mastoids in Planning Surgery for Chronic Suppurative Otitis Media.

Authors:  Pritam Chatterjee; Swagata Khanna; Ramen Talukdar
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-07-01

2.  MRI for the diagnosis of recurrent middle ear cholesteatoma in children--can we optimize the technique? Preliminary study.

Authors:  Anne Geoffray; Myriam Guesmi; Jean François Nebbia; Béatrice Leloutre; Sonanda Bailleux; Claude Maschi
Journal:  Pediatr Radiol       Date:  2012-11-18

3.  [Cholesteatoma of the middle ear - retrospective study about 145 cases].

Authors:  Brahim Bouaity; Mehdi Chihani; Karim Nadour; Mountassir Moujahid; Mliha Touati; Youssef Darouassi; Haddou Ammar
Journal:  Pan Afr Med J       Date:  2014-03-06

4.  Posttraumatic cholesteatoma complicated by a facial paralysis: a case report.

Authors:  M Chihani; A Aljalil; M Touati; B Bouaity; H Ammar
Journal:  Case Rep Otolaryngol       Date:  2012-02-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.